AXSM — Axsome Therapeutics, Inc.
9 mentions in the last 24 hours · 0.07% of all mentions
Why people talked about AXSM (2026-11-02)
- Axsome Therapeutics reported its financial results for the third quarter of 2026.
- The company's reported EPS of -$0.25 beat the estimated loss of -$0.64.
- Revenue of $259.7 million also exceeded the $248.6 million estimate.
| Bluesky | 4 | community |
| GDELT | 2 | news |
| Marketaux | 1 | news |
| RSS Bundle | 1 | news |
| SEC EDGAR 8-K | 1 | filings |